Trial shows benefits of Precision Spectra spinal cord stimulator system in low back pain-Boston Scientific

Boston Scientific has presented new data demonstrating that the Precision Spectra Spinal Cord Stimulator (SCS) System provides 1.5 times better overall pain relief and 2 times better low back pain relief than the previous generation Precision Plus SCS system. The improved outcomes with the Precision Spectra System were achieved in conjunction with the use of the proprietary Illumina 3D neural targeting software, designed to target pain with point-and-click simplicity.

The main findings include a sustained and highly significant reduction in overall pain from an average baseline score of 7.17 to 2.98 at 24 months post-implant (N= 117), as measured on the 0-10 numeric rating scale (NRS), and in a subset of patients with only low back pain (N=51), a sustained and highly significant reduction from an average baseline score of 7.21 to 3.20 at 24 months post-implant.

Data also showed a significant reduction in disability (N=51), maintained out to 12 months, as measured by the Oswestry Disability Index. Results from the LUMINA cohort of the Precision Spectra System observational study were presented at the International Neuromodulation Society 12th World Congress.